Q1 Financial and Business Update

May 13, 2025 - 8:00 am ET

1-833-821-0158 (US or Canada) or 1-647-846-2266 (International)

Investor Relations Contact Information

T: 215-825-9306

IR@adaptimmune.com

For other contact information, please visit the Contact page.